Toggle sidebar
Toggle sidebar
全部
智能回答
Search
Search
定价
登录
Rare - disease drug development
搜索文档
This Biotech Stock Soared 1,400%. Investors Are Optimistic About Its Rare-Disease Drug.
Barrons
·
2025-10-07 21:44
公司事件 - 公司股价创下有史以来最佳单日表现 [1] - 美国FDA授予其罕见病药物突破性疗法认定 [1]
Spruce Biosciences(US:SPRB)
Rare - disease drug development
Biotech
Rare - disease drug
Rare - disease drug development
Biotech
Rare - disease drug